OrthoEvolution
ActiveSummary
OrthoEvolution has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €48,174 and a net result of €273,713. Equity is shrinking by about 19% per year across the filed financial years. Its solvency ranks better than 16% of 20,320 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
31-05
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial
Highest result from 2021 to 2025net €273,713 ▲3.8%
Operating result €422,285, net result €273,713, both a record.
31-12
Financial
Liquidity more than quadruplescurrent ratio 9.42
Current ratio from 2.00 to 9.42; short-term debt falls from €53,628 to €38,707.
29-08
NBB filing
Annual accounts filed
financial year 2024 · micro format · 29 days late
2024
20-06
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
16-08
NBB filing
Annual accounts filed
financial year 2022 · micro format · 16 days late
2022
31-12
Financial
Equity above €200,000equity €222,985 ▲141%
A profit in every financial year since 2021 builds equity to €222,985.
31-08
NBB filing
Annual accounts filed
financial year 2021 · micro format · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.